‘Candidates wasting seats will be debarred from counselling’- AFMS warns NEET PG candidates, check details

New Delhi- “Any candidate who causes a lapse/ wastage of seat will be debarred from participating in counselling for admission in to AFMS Institutions in the upcoming years and be liable to face any action including legal from the competent authority”- the Armed Forces Medical Services (AFMS) recently stated in a notice issued for Priority- III Candidates (Medical Officers Sponsored By Para Military Organizations And Other Govt Of India Organizations) for PG medical admissions this year at AFMS institutes 2024-27 academic year.

The institute said, “Candidature of Priority-III candidates who choice-fill/ select subjects for which they are not sponsored vide the Sponsorship Certificates forwarded to this office by their parent organization are liable to be summarily rejected.”

In this regard please refer to para 19 & 23 (c) of the Information Bulletin for PG Courses (MD/MS/DNB/MDS) in AFMS Institutions through NEET PG 2024 & NEET MDS 2024’. The sections say:

19. A candidate shall not be eligible to take admission in AFMS Institutions if he/ she
has ‘cancelled’/ ‘failed to report for admission within the stipulated time’/ ‘vacated a
seat mid course in the past’, which has resulted in lapse/ wastage of a seat.

23 c) c) Priority-III candidates will be considered eligible for admission in AFMS
Institutions only for those subjects, which are mentioned in their sponsorship
certificate as forwarded by the respective sponsoring authority. In case a
Priority-III candidate is allotted a seat during the counselling conducted by the
MCC which is not mentioned in the Sponsorship Certificate forwarded by the
sponsoring organization, admission in AFMS PG Teaching Institutes would not
be granted and the candidate would be liable to suffer the consequences.

 It is further reiterated that any candidate who causes a lapse/ wastage of seat will be debarred from participating in counselling for admission in to AFMS Institutions in the upcoming years and be liable to face any action including legal from the competent authority, the AFMS said.

To view the official Notice, Click here : https://medicaldialogues.in/pdf_upload/notice-for-priority-iii-candidates-for-md-ms-dnb-courses-through-neet-pg-exam-2024-in-afms-institutions-for-the-academic-session-2024-2027-277488.pdf

Powered by WPeMatico

‘Assessors Did not Identify Any Deficiencies!’- DY Patil Medical College Pune says after NMC Letter

New Delhi: Soon after the National Medical Commission (NMC) sought action taken report from the DY Patil Medical College, Pune on several allegations, the college released a statement highlighting that the Commission’s assessors’ team did not find any violations during inspections.

Clarifying that during multiple inspections, no such deficiencies were identified, the college mentioned in its statement that it has already responded to the queries raised by NMC and it continues to comply with the regulations, reports Edex Live

Medical Dialogues had earlier reported that taking cognizance of several allegations concerning medical students, their training and the functioning of the institute, NMC recently directed the DY Patil Medical College, Pune to look into the matter and furnish an action taken report within a week.

NMC wrote to the medical college in this regard after receiving a complaint alleging several deficiencies in the medical college including infrastructure and space constraints, irregularities and financial concerns, stipend deductions, issues with the district residency programme, deficiencies in medical training and patient care, and concerns regarding surgical training.

Accordingly, in a letter dated 04.03.2025, NMC asked the college to immediately look into the matter and furnish an Action Taken Report to the Postgraduate Medical Education Board of the Commission within 7 days.

Also Read: Fake Files, Stipends deductions, Poor Training – DY Patil Medical College Pune Under NMC Scanner

As per the NMC letter, the college campus houses multiple institutes leading to “congestion and resource limitations” and it also lacks a playground and parking space for the resident doctors. Allegations were also raised claiming that the college was maintaining fake files, additional payments were being collected from students for faculties and resident publication, stipend deductions were being carried out arbitrarily, and fake scholarship documents were being submitted to the UGC. It was further alleged the medical college was inadequately implementing the District Residency Program. Besides, the complainant also highlighted deficiencies in medical training and patient care and concerns regarding surgical training.

The issue was also raised by the National President of the United Doctors’ Front (UDF) Dr Lakshya Mittal who shared copies of the NMC’s letter to the medical college.

However, the college has now defended itself clarifying that the NMC assessors did not find any deficiencies while conducting inspection at the medical college. 

Sharing a statement on the issue with Edex Live, the college mentioned, “Dr DY Patil Medical College, Hospital & Research Centre, Pimpri, Pune, is committed to excellence in medical education, infrastructure and patient care. We adhere to all regulatory standards and have consistently met the highest benchmarks in every inspection. The NMC follows a procedural approach in seeking clarifications for any queries raised. We categorically state that during multiple inspections, NMC assessors have not identified any deficiencies. We have responded to the NMC queries and continue to uphold regulatory compliance. Our institution remains committed to the highest standards of transparency, integrity and the relentless pursuit of medical excellence.”

Previously, the college was directed by the Postgraduate Medical Education Board (PGMEB) of the National Medical Commission (NMC) on 30.01.2025 to furnish its comments concerning the allegations of non-payment of stipends and mental harassment etc. Thereafter on 20.02.2025, the college informed that the complainant had collected all the documents and that the Complaint was false. However, NMC has observed that the college did not provide documentary proof for the payment of the stipend.

Also Read:NMC to introduce SOPs to address grievances on stipend, faculty, work hours

Powered by WPeMatico

Lupin unveils heart drug Rivaroxaban in US

Mumbai: Global pharma major Lupin Limited has announced that it has
launched
Rivaroxaban Tablets USP, 2.5 mg, following the final approval of its Abbreviated New Drug
Application (ANDA) from the US Food and Drug Administration (U.S. FDA).

Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto Tablets, 2.5 mg of JanssenPharmaceuticals, Inc..

It is indicated 

• to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD)

• to reduce the risk of major thrombotic vascular events in patients with peripheral artery disease
(PAD), including patients after recent lower extremity revascularization due to symptomatic
PAD.


Rivaroxaban Tablets USP, 2.5 mg (RLD Xarelto) had estimated annual sales of USD 446 million in the
U.S. (IQVIA MAT January 2025).

Medical Dialogues team had earlier reported that Lupin had received approval from the U.S.FDA for its  ANDA, Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg.

Read also: Lupin bags USFDA nod for Ipratropium Bromide Nasal Solution for rhinorrhea

Lupin Limited is a global pharmaceutical company headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. The company has a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally.

Read also: Lupin secures place in Prestigious S&P Global Sustainability Yearbook 2025

Powered by WPeMatico

Rajasthan MLA highlights Stipend Violations, overwork, recruitment issues in Assembly

Jaipur: Rajasthan MLA and
Congress leader Dr. Shikha Meel Barala raised significant concerns
about the state’s healthcare system during the Assembly session on March 6, 2025, including the pending Ayushman Bharat claims. 

Among the concerns were inadequate medical education due to a lack of
faculty and infrastructure, excessive duty hours for resident doctors, stipend
violations in private medical colleges, delays in Rajasthan Medical Education
Society (RajMES) recruitment, and lack of transparency in transfer policies.

One of the major issues
raised was the delayed payments under the Ayushman Bharat scheme, leaving
numerous beneficiaries waiting for their rightful claims. Citing data obtained
through the Right to Information (RTI) Act by the United Doctors’ Front (UDF),
she underscored the urgent need for addressing these lapses in the
implementation of the government’s flagship health insurance program.

Medical Dialogues recently reported that a total outstanding amount of Rs 1,21,61,45,63,617 (₹1.21 lakh crore) remains unpaid to empanelled hospitals under the Ayushman Bharat scheme (AB-PMJAY), with more than 63 lakh pending claims yet to be cleared, revealed the data shared by the National Health Authority (NHA) in response to a Right to Information (RTI) application. 

Dr. Barala also spoke
about the exploitative working conditions of resident doctors, who are often
forced to work long hours beyond permissible limits, particularly in private
medical institutions where stipend violations are rampant. Additionally, she
criticized the lack of transparency in transfer policies and the slow
recruitment process under RajMES, which has left many positions in government
healthcare institutions vacant.

Another controversial
matter she brought up was the appointment of Dr. Pramod Yeole as the
Vice-Chancellor of Rajasthan University of Health Sciences (RUHS), Jaipur.
Yeole, a pharmacist from Maharashtra, was deemed unqualified to lead a medical
university, drawing widespread backlash from doctors’ associations across
Rajasthan. Dr. Barala expressed gratitude to the United Doctors’ Front (UDF)
for consistently bringing these issues to public attention and emphasized the
need for immediate reforms to ensure better healthcare delivery in the state.

Dr Lakshya Mittal,
National President of UDF, took to his X account and appreciated Dr Barala for
putting forward the issue in the assembly, “A powerful stand for medical
fraternity! Hon’ble MLA, Rajasthan Dr. Barala ma’am, MS (OBGY) fearlessly
raised key issues in Rajasthan Vidhan Sabha Assembly. United Doctors Front
(UDF) thanks her for being our voice. The fight for better healthcare &
medical education continues!”

Powered by WPeMatico

Karnataka aims for Zero Maternal deaths, allocates Rs 320 crore

Bengaluru: Karnataka Chief Minister Siddaramaiah on Friday announced a significant allocation of Rs 320 crore to reduce preventable maternal mortality rate to zero in the state.

Presenting his 16th state budget, he highlighted several health infrastructure improvement projects that will be implemented in the year 2025-26.

Noting that Karnataka will introduce a pioneering policy focused on preventing and treating burn injuries among women, the Chief Minister said, “This will be a first of its kind initiative in the country.”

According to the PTI report, Siddaramaiah said the government will develop a mission-mode programme to reduce preventable maternal-mortality in the State to minimum. To this end, Rs 320 crore has been provided.

Also Read:Maternal Mortality Rate significantly reduced in Meghalaya, thanks to MOTHER Policy: Conrad Sangma

“Obstetric services will be strengthened by equipping hospitals with all necessary equipment to treat and prevent severe postpartum hemorrhage by leveraging novel digital technology. To prevent anemia among pregnant women, nutrition kits, financial incentives and Vatsalya Kits for mothers will be distributed in backward districts. MCH specialists will be deputed in every taluka hospital through re-deployment of posts,” he said.

The maternal mortality cases in the state will be subject to the audit of the State Technical Expert Committee and its recommendations will be submitted to the State Empowered Committee, he said.

“Programmes to reduce maternal mortality will be formulated based on Committee’s directives,” he added.

Last year, the state had witnessed a number of maternal deaths leading to outrage.

He said that a state-of-the-art and well equipped 200 bedded hospital will be constructed at a cost of Rs150 crore in Bengaluru North Taluk while PHCs (Primary Health Centre) of the newly announced taluks of Hanur, Alanavar, Annigeri, Maski, Sirivar, Kapu, Babaleshwar, Kolhar, Cheluru and Terdal will be upgraded to Community Health Centres (CHC).

A new CHC will be established in Ponnampet.

“Taluka Hospitals in Maluru, Magadi, Kushalanagar, Koratagere, Jagaluru, Savanuru, Ramadurga and Savadatti and the district hospital in Davangere and Wenlock Hospital in Mangaluru will be renovated at a cost of Rs 650 crore,” he said.

The CM said a new medical college will be established at Puttur. To this end, action will be initiated to upgrade the present 100-bedded Taluka hospital during this year.

“‘Gruha Aarogya Scheme” implemented on a pilot basis in Kolar district in 2024-25 to screen and treat six non-communicable diseases will be extended to the entire state at the cost of Rs 100 crore, he said.

According to Siddaramaiah, a 200-bedded hospital will be established at Molakalmuru in Chitradurga district and a 400-bedded hospital will be established at Virajapete in Kodagu district and the Community Health Centre at Tagaduru in Mysuru district will be upgraded to a 100-bedded hospital.

District and Taluk hospitals which require extensive repairs will be renovated at a cost of Rs 183 crore in a phased manner.

“To provide quality health services, to improve the health indicators and strengthen health systems in Kalyana Karnataka region under the Kalyana Karnataka Comprehensive Health Scheme several initiatives have been undertaken at the cost of Rs. 873 crore,” he said, reports PTI.

Siddaramaiah said that a cancer diagnosis unit will be started in Bidar Government Medical College Hospital and Institutes modelled on NIMHANS will be established at Mysuru and Kalaburagi Medical Colleges each at a cost of Rs 100 crore.

A super specialty hospital will be set up under Koppal Institute of Medical Sciences at a cost of Rs 100 crore and a Kidwai Peripheral Cancer treatment unit will be set up on the campus of Rajiv Gandhi Super Specialty Hospital in Raichur at Rs 50 crore.

Also Read:India can lead in shaping Maternal and Child Healthcare Strategies for Developing Nations: PMNCH’s Rajat Khosla

Powered by WPeMatico

No Proposal for Maternity Hospital in Pulwama: Sakina Masood Itoo

Pulwama: During a legislative assembly session, MLA Waheed Ur Rehman Para from Pulwama raised a question regarding the construction of a 100-bed maternity hospital in Sirnoo village, Pulwama district, South Kashmir. In response, the Minister for Health and Medical Education, Sakina Masood Itoo, clarified that there is no proposal for such a hospital at present. 

Health Minister Itoo stated that maternal healthcare services for the people of Pulwama, including Sirnoo, are being provided at the District Hospital in Pulwama. She noted that, currently, there are no plans for a separate maternity hospital.

The minister further explained that the government’s current focus is on strengthening and consolidating the existing healthcare infrastructure rather than building new facilities. Itoo also mentioned that Jammu and Kashmir is home to around 4,000 healthcare institutions across primary, secondary, and tertiary levels.

According to a report by the Ministry of Health and Family Welfare (MoHFW), the region is performing better than the national average in terms of healthcare accessibility. The report states that Jammu and Kashmir have one healthcare institution for every 3,500 people, compared to the national average of one for every 6,000 people.

The health minister added that any future upgrades or new projects in the healthcare sector would be dependent on various factors, including population density, existing healthcare infrastructure, proximity to other healthcare facilities, and compliance with the Indian Public Health Standards (IPHS) norms for 2022.

Also Read: 2000-bed state-of-the-art hospital to come up in Chandigarh

According to Rising Kashmir, the health minister said, “Furthermore, a recent Finance Department order (10-F of 2025, dated January 11, 2025) has restricted the creation of new posts, limiting the scope for expanding health services through new constructions.

To improve healthcare services, the government has conceptualized a plan to strengthen the existing health infrastructure through rationalization of manpower, resource sharing, and digital healthcare initiatives. This includes the expansion of e-Sanjeevani and telemedicine facilities, using a hub-and-spoke model to enhance accessibility.”

The 100-bed maternity hospital in Sirnoo village has been a long-standing concern for local residents. According to reports, around 2018-19, several canals of state land on the outskirts of Sirnoo village were designated for the proposed hospital, and a signboard was even installed at the site to mark the location. Speaking to Rising Kashmir, an aged resident of Sirnoo said that a road to the site was also opened by the then-deputy commissioner Pulwama.

Also Read: 300-bedded hospital spanning over 25 acres to come up in Jharkhand

However, the project has seen no progress over the past six years, leading to growing concerns and frustrations among the local community. Following this, MLA Waheed Ur Rehman Para raised the issue in the legislative assembly, seeking clarification from the government on whether the proposal for the maternity hospital was still pending approval or if there were any plans to revive the project soon.

Powered by WPeMatico

Spore-forming microbial whole-cell sensing strategy promising strategy against diabetes management: Study

A new study published in the journal of Nature Microsystems & Nanoengineering found that spore-forming microbial whole-cell sensing strategy to be a promising strategy in the management of diabetes. Elevated blood glucose levels is a hallmark of diabetes, a chronic metabolic condition that can cause serious side effects such blood vessel damage, diabetic retinopathy, renal failure, neuropathy, and cardiovascular disorders. If left untreated, these consequences might lead to serious health problems and even death.

A tiny proportion of diabetes patients are type 1 diabetes, an autoimmune disease that need frequent insulin injections and strict glucose monitoring. Systems for continuous glucose monitoring provide real-time information and a thorough knowledge of blood glucose levels over time. With the use of a spore-forming microbial whole-cell sensing system, this work presents a unique approach to glucose detection. In an engineered paper-based microbial fuel cell (MFC) solves those problems by inducing spore germination in response to the presence and concentration of glucose, resulting in metabolically active cells that produce electricity.

Bacillus subtilis spores are selectively and sensitively germinated in response to glucose in potassium-rich body fluids like perspiration. The electrogenic activity of these cells, which is represented by electricity, acts as a self-powered transducing signal for glucose detection since the rate of germination and the quantity of metabolically active germinating cells are directly proportional to the concentration of glucose. These electrical power outputs are measured and visible through a small interface in a microengineered, paper-based microbial fuel cell, offering real-time alarms.

The self-replicating microorganisms provide resilience, while the dormant spores prolong shelf life. With a noticeably lower limit of detection at ~0.07 mM, the MFC showed an impressive sensitivity of 2.246 µW·(log mM)−1·cm−2 to glucose concentrations ranging from 0.2 to 10 mM. Even when a variety of interferences were present, the sensor’s remarkable selectivity allowed it to detect glucose with accuracy.

Comparative studies showed that the spore-based MFC is stable for long periods of time and quickly regains functionality when required, in contrast to traditional enzymatic biosensors, whose performance deteriorates dramatically over time even while inactive. The spore-forming microbial whole-cell sensing approach has a lot of potential for effective diabetes treatment and can be expanded to noninvasive wearable monitoring, resolving significant issues with existing technologies and opening the door for more sophisticated biosensing applications.

Reference:

Gao, Y., Elhadad, A., & Choi, S. (2024). Revolutionary self-powered transducing mechanism for long-lasting and stable glucose monitoring: achieving selective and sensitive bacterial endospore germination in microengineered paper-based platforms. In Microsystems & Nanoengineering (Vol. 10, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1038/s41378-024-00836-9

Powered by WPeMatico

Study Suggests Shorter Driving Restrictions After STEMI, Challenges Outdated Guidelines

Canada: A new study highlights that the guidance patients receive from physicians regarding resuming driving after a ST-segment elevation myocardial infarction (STEMI) may be outdated despite its personal and economic significance.

Findings from the DRIVE-STEMI study indicate that the risk of death within the first year after hospital discharge remains below 5%, with low incidence rates of cardiac events such as cardiac arrest, syncope, stroke, MI, and hospitalization for rhythm disturbances. The DRIVE-STEMI study was initially presented as a poster at the American College of Cardiology (ACC) 2024 Scientific Session and later published as a research letter in Circulation on January 21, 2025.

The researchers note that several countries, including Canada, the United Kingdom, and Australia, have established guidelines to help medical professionals advise patients on resuming driving after a STEMI. However, in the absence of randomized trials on driving fitness, these recommendations rely largely on observational data from patients with various medical conditions. Suggested waiting periods vary widely, ranging from a few days to four weeks, and many guidelines use sudden cardiac death as a surrogate endpoint.

According to the researchers, the new study is the first to evaluate a composite of clinical outcomes under the term “sudden cardiac incapacitation” as an indicator of driving fitness.

For the study, Luiz F. Ybarra, Western University, London, Canada, and colleagues utilized administrative health databases to establish a cohort of 24,890 STEMI patients (mean age 63 years; 27% women) discharged between April 2017 and March 2021.

The following were the key findings of the study:

  • Within the first year, 4.9% of patients died, 0.6% experienced cardiac arrest, 1.7% had syncope, 0.7% suffered a stroke, and 2.7% had a myocardial infarction.
  • Hospitalization or emergency department visits occurred in 2.1% of patients for sustained arrhythmia and 0.3% for ventricular tachyarrhythmia.
  • Most events took place within the first 15 days after discharge.
  • The primary composite endpoint, including death, cardiac arrest, syncope, stroke, MI, and hospitalization or emergency visit for sustained arrhythmia, occurred in 11% of the cohort at one year.
  • The secondary composite endpoint, which included death, cardiac arrest, syncope, stroke, or sustained ventricular tachyarrhythmia, was observed in 7.4% of patients.
  • Among patients aged 65 or younger, the primary endpoint was seen in 6.7%, compared to 16.8% in those older than 65.
  • The secondary endpoint was observed in 3.9% of patients aged 65 or younger and in 12.1% of those over 65.
  • The difference between age groups was mainly driven by a higher all-cause mortality rate in older patients (9.1%) compared to younger patients (1.9%), with all comparisons showing statistical significance.

The researchers suggest that the optimal driving restriction period for the entire cohort is one month based on the primary endpoint, while the secondary endpoint indicates a shorter restriction of just two weeks. For younger patients, a two-week restriction may be appropriate according to the primary endpoint, with no restriction needed based on the secondary endpoint.

Since the primary difference between age groups was all-cause mortality, which may have led to an overestimation of sudden cardiovascular incapacitation risk, the researchers believe that the ideal driving restriction for patients over 65 years could be even shorter than the endpoint-based estimates.

Reference:

Singer Z, Wijeysundera HC, Qiu F, et al. Driving restrictions and incapacitation vulnerability evaluation after ST-segment elevation myocardial infarction: DRIVE-STEMI study. Circulation. 2025;151:282-284.

Powered by WPeMatico

Insomnia, lack of sleep linked to high blood pressure in teens, suggests research

Teenagers who do not get the recommended amount of sleep may be at an increased risk for high blood pressure, according to preliminary research presented at the American Heart Association’s Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Scientific Sessions 2025. The meeting will be held in New Orleans, March 6-9, 2025, and features the latest science on population-based health and wellness and implications for lifestyle.

Poor sleep is a known risk factor for cardiovascular disease, which claims more lives each year in the U.S. than all forms of cancer and chronic lower respiratory disease combined, according to the American Heart Association’s 2025 Statistical Update. Teenagers need 8 to 10 hours of sleep each night, according to the American Academy of Sleep Medicine, yet the average high school student is estimated to sleep only 6.5 hours per weeknight.

Researchers studied a diverse group of more than 400 teenagers from the Penn State Child Cohort. Participants in the study self-reported insomnia on a questionnaire prior to enrolling in the lab-based sleep study. In the nine-hour overnight sleep study, called a polysomnography, sensors were attached to each participant’s head, face and body to measure their sleep duration objectively. The study also included three consecutive blood pressure measurements taken on the night of the sleep study about two-to-three hours before lights were turned off in the lab.

“We know that disturbed and insufficient sleep is associated with high blood pressure in adults, particularly in adults who report insomnia and sleep objectively less than six hours, but we do not yet know if these associations exist in adolescents,” said senior study author Julio Fernandez-Mendoza, Ph.D., a professor of psychiatry, neuroscience and public health sciences and director of behavioral sleep medicine at Pennsylvania State University College of Medicine in Hershey, Pennsylvania.

The researchers defined insomnia as reporting difficulty falling and/or staying asleep and defined objective short sleep duration as less than 7.7 hours, based on the median total time asleep in the lab-based sleep study. Teenagers in the study were considered to have elevated blood pressure if they had a systolic, or top number, measurement of 120 mm Hg or higher and a diastolic, or bottom number, measurement of 80 mm Hg or lower. They were considered to have stage 2 hypertension if they had an average systolic blood pressure measurement of 140 mm Hg or higher and/or an average diastolic measure of 90 mm Hg or higher, which aligns with the Association’s 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

The researchers found:

  • Teenagers who self-reported insomnia and slept less than 7.7 hours in the lab were five times more likely to have clinical hypertension than “good sleepers“ (participants who did not report insomnia and obtained sufficient sleep in the lab, defined as 7.7 hours or more).
  • Teenagers who slept less than 7.7 hours in the lab but did not report insomnia had nearly three times the risk of elevated blood pressure compared to the good sleepers.
  • Teens who self-reported insomnia but obtained sufficient sleep in the lab did not appear to be at higher risk for elevated blood pressure or stage 2 hypertension.

These findings suggest the combination of insomnia and inadequate hours of sleep likely contributes to more severe conditions than lack of sleep alone, the researchers noted.

“While we need to explore this association in larger studies on teens, it is safe to say that sleep health matters for heart health, and we should not wait until adulthood to address it,” Fernandez-Mendoza said. “Not all teens who complain of insomnia symptoms are at risk for cardiovascular issues, however, monitoring their sleep duration objectively can help us identify those who have a more severe form of insomnia and are at-risk for heart problems.”

Improving one’s sleep health is something everyone can do to improve their cardiovascular health and is a key component of the Association’s Life’s Essential 8. The key components of Life’s Essential 8 include eating healthy food, being physically active, not smoking, getting enough sleep, maintaining a healthy weight and controlling cholesterol, blood sugar and blood pressure levels.

Our findings are important because they call attention to the need to listen to teens who complain of disturbed sleep, to monitor and assess their sleep objectively and help them improve it in order to prevent heart problems early,” said the study’s first author Axel Robinson, a 17-year-old senior at Pelham Memorial High School in Pelham, New York.

Robinson, whose high school offers a four-year science research program, read one of Fernandez-Mendoza’s scientific articles when he was in ninth grade and reached out to Fernandez-Mendoza, asking him to become his research mentor. “I have always been personally interested in insomnia, so I pursued two internships with Dr. Fernandez-Mendoza with the goal of learning more about the disorder. Insomnia had bothered me my entire life and I was able to overcome it thanks to what I learned and a therapist he recommended,” he said.

Study details, background and design:

  • The study group included 421 participants (54% boys and 46% girls, average age 16.5 years) from three school districts in the Harrisburg, Pennsylvania, metropolitan area. 77% of participants self-identified as white; 13% self-identified as Black; 7% self-identified as Hispanic; and 3% selected “Other.”
  • The overnight sleep study and blood pressure measurements occurred between 2010 and 2013, and data analyses were conducted between 2023 and 2024.
  • Of the participants, 35% reported difficulty falling and/or staying asleep (insomnia symptoms) and 50% slept less than 7.7 hours in the lab (objective short sleep duration).
  • Data was collected between 2010 and 2013 through self-reported questionnaires, a polysomnography (a sleep study conducted in a lab) and seated blood pressure measurements collected in the lab the same evening of the sleep studies.
  • The Penn State Child Cohort is ongoing and collecting data from the same participants, now ages 20 to 33 years old.

The study’s limitations include that it was conducted in a sleep lab, so participants might not have slept as well as if they were at home. Additionally, because all data collection took place between 2010 and 2013, “It is uncertain whether there may be post-COVID increases in adolescent insomnia, depression and anxiety that could impact the results of other studies when replicated now,” Fernandez-Mendoza noted.

“This study adds to the limited knowledge base about the relation between poor sleep and risk of hypertension during a crucial life stage of development,” said Brooke Aggarwal, Ed.D., M.S., FAHA, an assistant professor of medical sciences in the department of medicine’s division of cardiology at Columbia University Medical Center and a member of the Association’s Lifestyle Sleep Health Science Committee.

“Prevention of heart disease is key, and it begins with the adoption of a healthy lifestyle in childhood and adolescence, including optimal sleep. Setting healthy sleep patterns during the teenage years could carry over into adulthood. Similarly, sleep problems that occur during the teen years tend to persist over time and could predispose individuals to increased cardiovascular risk later in life,” said Aggarwal, who was not involved in the study.

“Besides treatment for any clinical sleep disorders, teens can also practice good sleep hygiene, including creating relaxing bedtime routines, limiting electronics use in the hours before bedtime, avoiding heavy meals before bed, restricting caffeine and participating in daily physical activity.”

This year, daylight saving time begins on Sunday, March 9. Daylight saving time is the practice of setting the clocks an hour ahead of standard time to achieve longer evening daylight in the summer months. Following good sleep hygiene, as well as getting as much natural light as possible each day and winding down earlier in the evenings ahead, can help to get ahead of the time change.

“Many people, including teens, struggle to adjust and their sleep suffers. Before we all spring ahead, I’d encourage parents and teens to talk about the importance of sleep and make a plan to adjust schedules to ensure everyone gets adequate sleep,” Aggarwal said.

Reference:

Insomnia, lack of sleep linked to high blood pressure in teens, American Heart Association, Meeting: AHA Epidemiology Lifestyle Scientific Sessions 2025.

Powered by WPeMatico

Children with Well-Managed Type 1 Diabetes Show Arterial Changes: Research Stresses Early Intervention

Sweden: A study published in eClinicalMedicine reported that children with well-managed type 1 diabetes exhibited greater intima thickness in certain arteries than their healthy counterparts. The research, conducted on 45 children with diabetes and 37 without, utilized ultra-high-frequency ultrasound to identify early vascular changes, underscoring the crucial role of maintaining normoglycemia in preventing cardiovascular complications.   

The authors emphasized that maintaining normoglycemia is crucial for cardiovascular prevention in children with type 1 diabetes, alongside early monitoring and potential pharmaceutical intervention for hypertension and hyperlipidemia. They highlighted the need for sensitive methods to detect and evaluate vascular changes over time, particularly in well-controlled pediatric diabetes populations like the study cohort.

The researchers note that cardiovascular complications remain a major concern in type 1 diabetes, with early atherosclerosis linked to hyperglycemia, hypertension, and dyslipidemia. Despite advances in diabetes management, children with type 1 diabetes continue to exhibit modifiable cardiovascular risk factors, highlighting the need for individualized prevention strategies.

To address this, Ebba Bergdahl, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden, and colleagues used ultra-high-frequency ultrasound (UHFUS) to detect subtle vascular changes in children with well-regulated diabetes, aiming to explore associations with glycemic and metabolic markers for early intervention.

For this purpose, the researchers conducted a cross-sectional case-control study at Queen Silvia Children’s Hospital, Gothenburg, Sweden, involving children with type 1 diabetes (CWD) aged 6–15.99 years with a diabetes duration of at least five years. Age- and sex-matched healthy controls were included for comparison. Participants with other medical conditions, treatments beyond insulin, abnormal findings, or difficulty undergoing examinations were excluded. UHFUS assessed the radial, dorsal pedal, and carotid arteries. Blood samples, blood pressure, BMI z-scores, and glucometrics were collected to evaluate vascular changes and metabolic markers.

Based on the study, the researchers reported the following findings:

  • The study was conducted from February 25, 2019, to June 28, 2022, and included 50 children with diabetes (CWD) and 41 healthy controls. After exclusions, data analysis included 45 CWD (22 girls, 23 boys; mean age 12.0 years) and 37 healthy controls (19 girls, 18 boys; mean age 11.3 years).
  • CWD had a mean HbA1c of 6.6% (48.1 mmol/mol).
  • There were higher diastolic blood pressure (DBP) z-scores in CWD.
  • CWD had significantly increased dorsal pedal (DP) intima thickness (IT), DP intima-media thickness (IMT), and radial IT compared to controls.
  • In CWD, carotid IT was negatively correlated with time in range (r = −0.47) and time in tight range (r = −0.64), while it was positively correlated with glucose variability (r = 0.40).
  • Time in tight range and longitudinal HbA1c were the strongest determinants for carotid IT in CWD.
  • Type 1 diabetes diagnosis was the strongest determinant of IT across all arteries.

The researchers found that children with well-regulated type 1 diabetes exhibit early vascular changes in the radial and dorsal pedal arteries. Regression analyses highlighted strong associations between intima thickness and hyperglycemia and type 1 diabetes diagnosis, suggesting that structural arterial changes originate in the intima.

“Their findings reinforce the importance of maintaining normoglycemia to prevent cardiovascular complications. We emphasize the need for larger studies to validate these results and further explore their clinical implications,” the researchers concluded.

Reference:

Bergdahl, E., Forsander, G., Sundberg, F., Milkovic, L., & Dangardt, F. (2025). Investigating the presence and detectability of structural peripheral arterial changes in children with well-regulated type 1 diabetes versus healthy controls using ultra-high frequency ultrasound: A single-centre cross-sectional and case-control study. EClinicalMedicine, 81, 103097. https://doi.org/10.1016/j.eclinm.2025.103097

Powered by WPeMatico